Loading...

Renal Cell Carcinoma: Focus on Safety and Efficacy of Temsirolimus

Metastatic renal cell carcinoma has harboured a poor prognosis for decades with immunotherapy being the only available therapy with high toxicity and modest effect. Dependance of renal cell carcinoma oncogenesis on the mTOR pathway has led to clinical development of temsirolimus in this setting. Thi...

Full description

Saved in:
Bibliographic Details
Main Authors: Hadoux, Julien, Vignot, Stephane, De La Motte Rouge, Thibault
Format: Artigo
Language:Inglês
Published: Libertas Academica 2010
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3018897/
https://ncbi.nlm.nih.gov/pubmed/21234295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/CMO.S4482
Tags: Add Tag
No Tags, Be the first to tag this record!